Strides receives USFDA approval for its tablets

Strides Pharma Science Ltd. on Tuesday said its step-down wholly owned subsidiary, Strides Pharma Global Pte. Ltd., Singapore, had received approval from the United States Food and Drug Administration for Butalbital, Acetaminophen, and Caffeine tablets USP, in strengths of 50 mg/325 mg/40 mg, indicated for relief of “symptom complex of tension headache”.

Show Less Plan

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Faster pages

Move smoothly between articles as our pages load instantly.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.


A one-stop-shop for seeing the latest updates, and managing your preferences.

Personalised recommendations

A select list of articles that match your interests and tastes.


We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

Source link

Posts You May Love to Read !!

Leave a Comment